Chapter 2 Summary and Highlights
- Market Outlook
- Highlights of the Artificial Organs Market
Chapter 3 Market Overview and Definitions
- Overview
- Artificial Organs
Chapter 5 Market Breakdown by Product Type
- Introduction
- Artificial Heart
- Artificial Kidney
- Artificial Lung
- Artificial Pancreas
- Cochlear Implant
Chapter 6 Covid-19 Impact Analysis
- Introduction
- Covid-19 Impact on the Medical Devices and Pharmaceutical Industries
- Decline/Delay in Elective Procedures
- Impact of Covid-19 on Medical Device and Pharmaceutical Product Segments
- Covid-19 Impact on Artificial Organs Markets
Chapter 7 Market Breakdown by Region
- Market Overview and Discussion
- North America
- U.S.
- Canada
- Mexico
- Latin America
- Brazil
- Argentina
- Chile
- Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Chapter 8 Competitive Landscape
- Industry Scenario
- Company Shares
Chapter 9 Emerging/Upcoming Technologies
- Key/Emerging Technologies/Trends in the Market
- Tissue Engineering and Regenerative Medicine
- Organ-On-A-Chip
- Bio-Fabrication and 3D Bioprinting
- Biomaterials and Biocompatible Materials
- Immunomodulation and Immunotolerance Strategies
- Neural Interfaces and Brain-Machine Interfaces
- Gene Editing and Gene Therapy
Chapter 10 M&A and Fundings Outlook
- M&A Analysis
- Syncardia System's Acquisition by Versa Capital Management
- Abiomed's Acquisition of Berlin Heart
- Livanova's Acquisition of Tandemlife
- Fresenius Medical Care's Acquisition of Nxstage Medical
- B. Braun's Acquisition of Nxstage Medical's Bloodlines Business
- Livanova's Acquisition of Tandemlife
- Cantel Medical's Acquisition of Hemodialysis Business from Gambro
- Eli Lilly's Acquisition of Protomer Technologies
- Johnson & Johnson Acquisition of Abiomed Inc.
Chapter 11 Sustainability in Artificial Organs Market: An Esg Perspective
- Introduction
- Environmental Factors
- Social Factors
- Governance Factors
- Artificial Organs Market: Esg Performance Analysis, by Company
- Conclusion
Chapter 12 Patent Analysis
- Patent Analysis by Manufacturer
Chapter 13 Pipeline Analysis
Chapter 14 Company Profiles
- Abiomed
- Abbott
- Baxter International Inc.
- B. Braun Se
- Cochlear Ltd.
- Fresenius Medical Care AG & Co. Kgaa
- F. Hoffmann-La Roche AG
- Getinge Ab
- Insulet Corp.
- Livanova plc
- Medtronic
- Med-El Medical Electronics
- Nipro Corp.
- Sonova
- Terumo Corp.
- Tandem Diabetes Care, Inc.
- Ypsomed Ag
List of Tables
Summary Table: Global Market for Artificial Organs, by Product Type, Through 2028
Table 1: Global Population, Aged 60 and Older, 2010-2050
Table 2: Diabetic Cases, by Country, 2000-2045
Table 3: Chronic Kidney Disease Cases, by Country, 2017-2023
Table 4: Global Market for Artificial Organs, by Product Type, Through 2028
Table 5: Global Market for Artificial Hearts, by Region, Through 2028
Table 6: Global Market for Artificial Kidneys, by Region, Through 2028
Table 7: Global Market for Artificial Lungs, by Region, Through 2028
Table 8: Global Market for Artificial Pancreases, by Region, Through 2028
Table 9: Global Market for Cochlear Implants, by Region, Through 2028
Table 10: Global Market for Artificial Organs, by Region, Through 2028
Table 11: North American Market for Artificial Organs, by Country, Through 2028
Table 12: Latin American Market for Artificial Organs, by Country, Through 2028
Table 13: European Market for Artificial Organs, by Country, Through 2028
Table 14: Asia-Pacific Market for Artificial Organs, by Country, Through 2028
Table 15: RoW Market for Artificial Organs, Through 2028
Table 16: Medtronic ESG Performance
Table 17: Abbott ESG Performance
Table 18: Cochlear Ltd. ESG Performance
Table 19: Artificial Heart Patents, by Organization, 2019-2022
Table 20: Artificial Kidney Patents, by Organization, 2019-2022
Table 21: Artificial Lung Patents, by Organization, 2019-2022
Table 22: Artificial Pancreas, by Organization, 2019-2022
Table 23: Cochlear Implants, by Organization, 2019-2022
Table 24: Selected Artificial Heart Devices in Clinical Trials, 2023
Table 25: Selected Artificial Kidney Devices in Clinical Trials, 2023
Table 26: Selected Artificial Lung Devices in Clinical Trials, 2023
Table 27: Selected Artificial Pancreas in Clinical Trials, 2023
Table 28: Selected Cochlear Implants in Clinical Trials, as of 2023
Table 29: Abbott: Revenue, by Segment, 2020-2022
Table 30: Abbott: Revenue, by Region, 2020-2022
Table 31: Baxter International Inc.: Revenue, by Segment, 2020-2022
Table 32: Baxter International Inc.: Revenue, by Region, 2021 and 2022
Table 33: F. Hoffmann-La Roche Ltd.: Financials, 2020-2022
Table 34: F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2020-2022
Table 35: Getinge AB: Revenue, by Segment, 2020-2022
Table 36: Insulet Corp.: Revenue, by Segment, 2020-2022
Table 37: LivaNova: Revenue, by Segment, 2020-2022
Table 38: Nipro Corp.: Revenue, by Segment, 2020-2022
Table 39: Sonova: Revenue, by Segment, 2021 and 2022
Table 40: Sonova: Revenue, by Region, 2021 and 2022
Table 41: Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market for Artificial Organs, by Product Type, 2020-2028
Summary Figure B: Global Market Shares of Artificial Organs, by Product Type, 2022
Figure 1: Global Market for Artificial Organs, by Product, 2020-2028
Figure 2: Global Market Shares of Artificial Organs, by Product, 2022
Figure 3: Global Market for Artificial Hearts, by Region, 2020-2028
Figure 4: Global Market Shares of Artificial Hearts, by Region, 2022
Figure 5: Global Market for Artificial Kidneys, by Region, 2020-2028
Figure 6: Global Market Shares of Artificial Kidneys, by Region, 2022
Figure 7: Global Market for Artificial Lungs, by Region, 2020-2028
Figure 8: Global Market Shares of Artificial Lungs, by Region, 2022
Figure 9: Global Market for Artificial Pancreases, by Region, 2020-2028
Figure 10: Global Market Shares of Artificial Pancreases, by Region, 2022
Figure 11: Global Market for Cochlear Implants, by Region, 2020-2028
Figure 12: Global Market Shares of Cochlear Implants, by Region, 2022
Figure 13: Global Market Shares of Artificial Organs, by Region, 2022
Figure 14: North American Market Shares of Artificial Organs, by Country, 2022
Figure 15: Latin American Market Shares of Artificial Organs, by Country, 2022
Figure 16: European Market Shares of Artificial Organs, by Country, 2022
Figure 17: Asia-Pacific Market Shares of Artificial Organs, by Country, 2022
Figure 18: Global Market Shares of Artificial Organs, by Company, 2022
Figure 19: Global Market Shares of Artificial Heart, by Company, 2022
Figure 20: Global Market Shares of Artificial Kidney, by Company, 2022
Figure 21: Global Market Shares of Artificial Lung, by Company, 2022
Figure 22: Global Market Shares of Artificial Pancreas, by Company, 2022
Figure 23: Global Market Shares of Cochlear Implants, by Company, 2022
Figure 24: Emerging Trends/Technologies in the Artificial Organs Market
Figure 25: Abiomed: Company Revenue, 2020-2022
Figure 26: Abbott: Company Revenue, 2020-2022
Figure 27: Abbott: Revenue Share, by Segment, 2022
Figure 28: Abbott: Revenue Share, by Region
Figure 29: Baxter International Inc.: Company Revenue, 2020-2022
Figure 30: Baxter International Inc.: Revenue Share, by Segment, 2022
Figure 31: B. Braun: Company Revenue, 2020-2022
Figure 32: Cochlear: Implant Sales, 2020-2022
Figure 33: Fresenius Medical Care: Revenue, 2020-2022
Figure 34: Getinge AB: Company Revenue, 2020-2022
Figure 35: Insulet Corp.: Company Revenue, 2020-2022
Figure 36: LivaNova: Company Revenue, 2020-2022
Figure 37: Medtronic: Company Revenue, 2020-2022
Figure 38: Nipro Corp.: Company Revenue, 2020-2022
Figure 39: Nipro Corp.: Revenue Share, by Segment, 2022
Figure 40: Nipro Corp.: Revenue Share, by Region/Country, 2022
Figure 41: Sonova: Company Revenue, 2021 and 2022
Figure 42: Sonova: Revenue Share, by Segment, 2022
Figure 43: Sonova: Revenue Share, by Region, 2022
Figure 44: Tandem Diabetes Care: Company Revenue, 2020-2022
Figure 45: Ypsomed: Company Revenue, 2020-2022